10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,791 | -25.8% | 1,304 | +0.4% | 0.00% | – |
| Q2 2023 | $72,537 | +18.0% | 1,299 | +17.9% | 0.00% | – |
| Q1 2023 | $61,481 | +18.5% | 1,102 | -22.6% | 0.00% | – |
| Q4 2022 | $51,890 | -16.3% | 1,424 | -35.0% | 0.00% | – |
| Q3 2022 | $62,000 | -25.3% | 2,192 | +19.3% | 0.00% | – |
| Q2 2022 | $83,000 | -46.5% | 1,838 | -10.2% | 0.00% | – |
| Q1 2022 | $155,000 | +278.0% | 2,046 | +617.9% | 0.00% | – |
| Q4 2021 | $41,000 | +78.3% | 285 | +70.7% | 0.00% | – |
| Q3 2021 | $23,000 | -50.0% | 167 | -28.0% | 0.00% | – |
| Q2 2021 | $46,000 | +12.2% | 232 | +4.0% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 223 | +21.2% | 0.00% | – |
| Q4 2020 | $25,000 | +257.1% | 184 | +201.6% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 61 | +24.5% | 0.00% | – |
| Q2 2020 | $4,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |